Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04205552
Title Neoadjuvant Nivolumab Combination Treatment in Resectable Non-small Cell Lung Cancer Patients (NEOpredict)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors University Hospital, Essen
Indications

lung non-small cell carcinoma

Therapies

Nivolumab + Relatlimab

Nivolumab

Age Groups: adult | senior
Covered Countries DEU | BEL

Facility Status City State Zip Country Details
Jessa Hospital Hasselt Recruiting Hasselt Belgium Details
University Hospital Essen Recruiting Essen Germany Details
Netherlands Cancer Institute Not yet recruiting Amsterdam Netherlands Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field